Advocacy intelligence hub — real-time data for patient organizations
Sameek Roychowdhury — PHASE2
Cogent Biosciences, Inc. — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Milind Javle, MD, MD
Roswell Park Cancer Institute
📍 HOUSTON, TX
Manuel Häckl, MD
Basilea Pharmaceutica International Ltd, Allschwil
Sameek Roychowdhury, MD, PhD, M.D
Ohio State University Comprehensive Cancer Center
📍 COLUMBUS, OH
Tanguy Seiwert, M.D
University of Chicago Comprehensive Cancer Center P2C
📍 BALTIMORE, MD
Marc Engelhardt, MD, DR
Basilea Pharmaceutica
📍 MANCHESTER, MO
Mehmet Akce, MD, M.D
Sponsor-Investigator
📍 BIRMINGHAM, AL